LLY

NYSE · Pharmaceuticals

Eli Lilly and Co.

S&P 500 Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$1,364.73

-53.26 (-3.76%)

As of Nov 5, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 86%

Hold 4 11%

Sell 1 3%

Price Target

Analyst Price Target -2.5% upside

Low Target $960.24

Average Target $1,330.33

High Target $1,470.76

Current Price $1,364.73

Current
$1,364.73

Target
$1,330.33

$960.24 $1,330.33 avg $1,470.76

Scenario Analysis

Bear Case

$960.24

-29.6%

Low target

Base Case

$1,330.33

-2.5%

Avg target

Bull Case

$1,470.76

+7.8%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$1,408.38

-3.1% from high

52-Week Low

$809.63

+68.6% from low

50-Day SMA

$1,207.19

+13.1% vs SMA

200-Day SMA

$1,096.87

+24.4% vs SMA

RSI (14)

77.0

Overbought

Target vs 52W High

$1,330.33

-5.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-2.5%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+10.0%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+13.5%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+176.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.3%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+155.6%